Skip to Navigation


home > Company > History
  • 2021
    • Sep. Signed a non-cxclusive license agreement with Immunovia(Sweden)
      for the patent 'diagnostic biomarker of pancreatic cancer'
    • Aug. World's 1st Europeon&Chinese patent
      registration of diagnostic technique for sepsis
    • Jan. Equity invesrment to 'Onebiomed',
      a Singapore molecular diagnostic company
  • 2020
    • Feb. Obtainment of a US patent for an early diagnosis
      technology of pancreatic cancer
    • Jul. Obtainment of the patents for a diagnosis
      technology of septicemia both in US and Japan
  • 2019
    • Oct. Exclusive supply contract with JEOL biochemical equipment
  • 2018
    • Nov. Launched SANGRAY, the first X-ray blood irradiator in Korea
    • Sep. Released steam sterilizers JW-SS360, JW-SS270
    • Mar. Early detection of pancreatic cancer
      "Multiple biomarker diagnostic kit" Technology transfer
      contract signed (Yonsei University)
  • 2016
    • May. Signed a contract for early diagnosis of sepsis infection
      technology transfer
      ((Re)Pharmaceutical Bioconvergence Research Group)
    • Apr. Established JW Bioscience